Patient-related risk factors appear to be the primary driver of readmissions in hospitals serving a higher proportion of minority patients, according to a study published online yesterday by the journal Surgery. The researchers examined outcomes and patient factors in more than 168,000 colorectal surgery patients treated in 374 California hospitals from 2004-2011, including 47 hospitals with a high percentage of minority patients (63%) compared with the other hospitals (17%). They found that patient factors (such as race, low income and insurance status) accounted for up to 65% of the increased odds for readmission at the minority-serving hospitals, while hospital-level factors (such as procedure volume and type) accounted for up to 40%. The Centers for Medicare & Medicaid Services’ Hospital Readmissions Reduction Program penalizes hospitals for higher-than-expected readmission rates for certain conditions, the authors note. “These findings suggest that CMS should account for patient socio-economic factors when they compare readmission rates,” said Waddah Al-Refaie, M.D., the study’s senior investigator and chief of surgical oncology at MedStar Georgetown University Hospital in Washington, D.C.

Related News Articles

Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares insights into the organization’s bold approach to improving safety outcomes. From piloting…
Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Blog
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 awardEach day, health care professionals across the U.S. leverage…
Headline
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating…